We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.48%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.3B
AUM Growth
+$966M
(+8.6%)
Cap. Flow
+$867M
Cap. Flow
% of AUM
7.08%
Top 10 Holdings %
Top 10 Hldgs %
51.59%
Holding
825
New
217
Increased
182
Reduced
275
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BWP
Boardwalk Pipeline Partners
BWP
|
+$133M |
| 2 |
Enterprise Products Partners
EPD
|
+$114M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$66.3M |
| 4 |
Brookfield
BN
|
+$38.9M |
| 5 |
Baxter International
BAX
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cheniere Energy
CQP
|
+$77.7M |
| 2 |
GG
Goldcorp Inc
GG
|
+$33M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$23.8M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$19.4M |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$15.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 66.36% |
| 2 | Materials | 2.69% |
| 3 | Financials | 2.67% |
| 4 | Healthcare | 2.57% |
| 5 | Technology | 1.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEMG
176
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.32M | 0.02% |
65,497
+9,004
| +16% | +$286K |
|
177
Boston Properties
BXP
$11B
| $2.25M | 0.02% |
16,497
-970
| -6% | -$135K |
|
|
DBVT
178
DBV Technologies
DBVT
$807M
| $2.23M | 0.02% |
6,146
-626
| -9% | -$217K |
|
|
IPXL
179
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.23M | 0.02% |
94,158
-9,535
| -9% | -$256K |
|
|
ALDR
180
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.1M | 0.02% |
+63,978
| New | +$1.95M |
|
|
ISEE
181
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.09M | 0.02% |
45,374
-4,315
| -9% | -$243K |
|
182
Supernus Pharmaceuticals
SUPN
$2.68B
| $2.03M | 0.02% |
82,110
+12,684
| +18% | +$287K |
|
183
Halozyme
HALO
$9.72B
| $1.99M | 0.02% |
164,982
-16,371
| -9% | -$167K |
|
|
ASRT
184
DELISTED
Assertio
ASRT
| $1.96M | 0.02% |
1,304
-127
| -9% | -$159K |
|
185
Vornado Realty Trust
VNO
$7.47B
| $1.92M | 0.02% |
23,431
-1,440
| -6% | -$119K |
|
|
AAAP
186
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $1.91M | 0.02% |
50,073
-5,105
| -9% | -$170K |
|
187
Healthpeak Properties
DOC
$15.4B
| $1.9M | 0.02% |
54,829
-3,423
| -6% | -$120K |
|
|
SAGE
188
DELISTED
Sage Therapeutics
SAGE
| $1.88M | 0.02% |
40,914
-4,130
| -9% | -$168K |
|
189
Realty Income
O
$61.2B
| $1.86M | 0.02% |
28,680
-624
| -2% | -$41.2K |
|
|
SIOX
190
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.77M | 0.01% |
15,802
-1,609
| -9% | -$193K |
|
|
CLVS
191
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.77M | 0.01% |
49,083
-4,841
| -9% | -$104K |
|
|
XLRN
192
DELISTED
Acceleron Pharma
XLRN
| $1.74M | 0.01% |
47,930
-4,357
| -8% | -$144K |
|
|
GGP
193
DELISTED
GGP Inc.
GGP
| $1.72M | 0.01% |
62,295
-4,081
| -6% | -$122K |
|
194
TherapeuticsMD
TXMD
$23.8M
| $1.71M | 0.01% |
5,010
-504
| -9% | -$184K |
|
|
KYNB
195
Kyntra Bio
KYNB
$28.5M
| $1.66M | 0.01% |
3,202
-307
| -9% | -$145K |
|
|
PTLA
196
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.64M | 0.01% |
72,029
-7,299
| -9% | -$171K |
|
197
Emergent Biosolutions
EBS
$375M
| $1.63M | 0.01% |
51,578
-16,730
| -24% | -$486K |
|
198
Pacira BioSciences
PCRX
$1.02B
| $1.63M | 0.01% |
47,524
-4,688
| -9% | -$184K |
|
|
SA
199
Seabridge Gold
SA
$2.8B
| $1.58M | 0.01% |
143,397
-78,917
| -35% | -$988K |
|
|
PVG
200
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.57M | 0.01% |
152,997
+16,824
| +12% | +$188K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, ALPS Advisors held 825 positions worth $12.3B, up 8.6% from $11.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ALPS Advisors deployed $867M of net new capital in Q3 2016, opening 217 new positions and adding to 182 existing holdings. Its largest new stake was Boardwalk Pipeline Partners: 7,906,111 shares worth $136M.
By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Materials and Financials.
On the sell side, the largest reduction was Cheniere Energy, an estimated $77.7M trimmed.
- ALPS Advisors's largest Q3 2016 buy was Boardwalk Pipeline Partners: 7,906,111 shares worth $136M.
- ALPS Advisors added most to Enterprise Products Partners in Q3 2016, an estimated $114M increase.
- ALPS Advisors's biggest Q3 2016 reduction was Cheniere Energy, cutting an estimated $77.7M.
- ALPS Advisors fully exited Goldcorp Inc in Q3 2016, selling an estimated $33M.
- ALPS Advisors's ten largest holdings make up 52% of its $12.3B portfolio in Q3 2016.
- ALPS Advisors opened 217 new positions and closed 151 in Q3 2016.
- ALPS Advisors's portfolio value rose 8.6% quarter-over-quarter to $12.3B.
Based on ALPS Advisors's 13F filing for Q3 2016, filed 2 Nov 2016.